![Gabriella Schivardi: Our study on the impact of molecular classes in stage IIIC endometrial cancer](https://oncodaily.com/pub/uploads/2024/08/S4Ro4A6k_400x400-e1724130658472.png)
Photo from Gabriella Schivardi/X
Aug 20, 2024, 13:21
Gabriella Schivardi: Our study on the impact of molecular classes in stage IIIC endometrial cancer
Gabriella Schivardi, Visiting Research Fellow of Department of Gynecology at Mayo Clinic, shared on X about a recent paper titled “Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study” published in BMJ Journals.
Authors: Gabriella Schivardi, Giuseppe Caruso, Luigi De Vitis, Giuseppe Cucinella, Francesco Multinu, Vanna Zanagnolo, Glauco Baiocchi, Louise De Brot, Tommaso Occhiali, Giuseppe Vizzielli, Robert Giuntoli, Angela Fought, Michaela McGree, Maryam Shahi, Andrea Mariani, Gretchen Glaser
“Just published online our study exploring the impact of molecular classes in stage IIIC endometrial cancer patients!”
Source: Gabriella Schivardi/X
Andrea Mariani
Angela Fought
cancer
Francesco Multinu
Gabriella Schivardi
Giuseppe Caruso
Giuseppe Cucinella
Giuseppe Vizzielli
Glauco Baiocchi
Gretchen Glaser
IJGC
IJGC Fellows
Louise De Brot
Luigi De Vitis
Maryam Shahi
Michaela McGree
OncoDaily
Oncology
Robert Giuntoli
Tommaso Occhiali
Vanna Zanagnolo
Aug 20, 2024, 13:04